|
FTH Faeth Therapeutics, Inc 1829802 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-170,236,000.00 |
| Balance Sheet |
|
Current Assets
|
$204,232,000.00 |
|
Assets
|
$205,381,000.00 |
|
Current Liabilities
|
$14,190,000.00 |
|
Liabilities
|
$14,191,000.00 |
|
Equity
|
$-137,286,000.00 |
|
Shares Out
|
1340333.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-10,733,000.00 |
|
Investing Cash Flow
|
$-31,436,000.00 |
| Market Analysis |
Market Cap
|
$38,628,397.06 |
|
Price
|
$26.92 |
|
PB
|
1.03 |
|
EPS
|
-131.45 |
|
FCF
|
$-10,739,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:50 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:53 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FTH documents filed with the SEC.
FTH Filings
Clear
